Posted on 26 January 2013.
Tofacitinib Slows Joint Damage in Rheumatoid Arthritis
(HealthDay News) – Tofacitinib slows the progression of joint damage and improves disease activity in patients with rheumatoid arthritis (RA), according to a study published online Jan. 24 in Arthritis & Rheumatism. Desiree van der Heijde, MD, PhD …
Full News here – Read more on Monthly Prescribing Reference